| __timestamp | Alnylam Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44526000 | 6795238 |
| Thursday, January 1, 2015 | 60610000 | 7454247 |
| Friday, January 1, 2016 | 89354000 | 10345862 |
| Sunday, January 1, 2017 | 199365000 | 16984203 |
| Monday, January 1, 2018 | 382359000 | 16187290 |
| Tuesday, January 1, 2019 | 479005000 | 9299233.54 |
| Wednesday, January 1, 2020 | 588420000 | 19232000 |
| Friday, January 1, 2021 | 620639000 | 23611000 |
| Saturday, January 1, 2022 | 770658000 | 26700000 |
| Sunday, January 1, 2023 | 795646000 | 28215000 |
| Monday, January 1, 2024 | 975526000 |
Unleashing the power of data
In the competitive world of biotechnology, managing expenses is crucial for success. Alnylam Pharmaceuticals, Inc. and Summit Therapeutics Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Alnylam's SG&A expenses have surged by over 1,600%, reflecting its aggressive growth strategy and expansion efforts. In contrast, Summit Therapeutics has maintained a more conservative approach, with expenses increasing by approximately 315% over the same period.
This divergence highlights the varied strategies companies employ to navigate the biotech landscape.
Operational Costs Compared: SG&A Analysis of Novartis AG and Alnylam Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Neurocrine Biosciences, Inc.
Alnylam Pharmaceuticals, Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Evotec SE